Buzz Pocket

Wednesday, February 17, 2021

Driving Innovation: Autotransfusion Devices Market - Future Growth, & Forecast to 2027

according to a recent report published by research dive, titled, “autotransfusion devices market by type, and application: global opportunity analysis and industry forecast, 2018-2027,” the global autotransfusion devices market size was $1,121.5 million in 2018, and is anticipated to reach $1,939.7 million by 2027, at 6.5% cagr from 2019 to 2027.

The North America regional market dominates the global market, followed by Europe, Asia-Pacific, and LAMEA. U.S. dominated the global autotransfusion devices market share in 2018, and is expected to grow at a significant rate during the forecast period.

Autotransfusion is a process wherein a person receives their own blood for a transfusion, instead of banked allogenic (separate-donor) blood. There are two main kinds of autotransfusion: Blood can be autologously “pre-donated” (termed so despite “donation” not typically referring to giving to one’s self) before a surgery, or alternatively, it can be collected during and after the surgery using an intraoperative blood salvage device (such as a Cell Saver or CATS). The latter form of autotransfusion is utilized in surgeries where there is expected a large volume blood loss – e.g. aneurysm, total joint replacement, and spinal surgeries. The device used for autotransfusion is called autotransfusion devices. Presently, many surgeons utilize autotransfusion innovatively such as with a cell processing step which not only is efficient and less time consuming but also enables the patient to have safe blood transfusion. Moreover changing lifestyles coupled with the increasing obesity amongst the masses has resulted in increased chances of having cardiac diseases which has prompted the growth of Autotransfusion devices.

Connect with Our Analyst to Contextualize Our Insights for Your Business: https://www.researchdive.com/connect-to-analyst/49

High occurrence of cardiac diseases leads to the huge demand of auto-transfusion device across the world. Furthermore, absence of any risk of transfusion or transmitted infections is boosting the growth for autotransfusion devices globally. On the contrary, inability to separate contaminants from blood is expected to be a major restraint for autotransfusion devices market. On the other hand, growing Adoption of whole body autotransfusion devices.

Off-Pump Autotransfusion devices holds the highest market share amongst the product type segment and is expected to grow with a CAGR of 6.6% during the forecast period 2019-2027. The driving factor for off-pump transfusion is the device usage ease, coupled with no blood loss feature during the transfusion process. Major trends in the off-pump transfusion is its efficacy and the fact that off-pump transfusion have much lower post-operative morbidity and mortality especially in high risk patients.

Amongst the end use segment, Hospital segment holds the largest market share and is expected to grow at CAGR of 6.6% during the forecast period. This primarily because, the hospitals have specialized departments wherein blood transfusion is required as such the autotransfusion devices are required in multiple numbers to cater to various transfusion requirements of specialized diseases in various department.

Download Exclusive Free Sample Copy of the Report at: https://www.researchdive.com/download-sample/49

North America has the highest market share for autotransfusion device globally and is expected to grow at a healthy rate of 6.4% over the forecast period. U.S, hold the majority of the share of the North America market and it is one of the leading countries globally. As the regulatory standards regarding transfusion are quite stringent in U.S., companies are investing a lot on Research & Development for approvals of commercial sale of Autotransfusion device and therefore they are focused on quality and innovative products so as to efficiently handle the process and edge ahead of competitors, thus driving the growth of Autotransfusion device in the country.

One of the prominent players in autotransfusion devices market viz., Medtronic plc announced it has received Breakthrough Device designation from the U.S. Food and Drug Administration (FDA) for its Personalized Closed Loop (PCL) insulin pump system, currently in development. The PCL technology is designed to automate insulin delivery in a way that is real-time, personalized and adapts to the user. The system will also provide insights and predictive diagnostics unique to the individual, with a goal of dramatically simplifying diabetes management for the patient. The recent acquisition of Nutrino Health and their expertise in nutrition data science will play a key role in the accelerated development of this breakthrough technology. Zimmer Biomet Holding, Becton Dickinson and Company, LivaNova, Plc, Teleflex Incorporated, Stryker Corporation, Fresenius Medical Care AG & Co. KGaA, Terumo Corporation, Haemonetics Corporation and Getinge AB.

Contact Us:

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
+1 (917) 444-1262 (US) Toll
Free : +1 -888-961-4454
Email: support@researchdive.com
LinkedIn: https://www.linkedin.com/company/research-dive
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive
Blog: https://www.researchdive.com/blog
Follow us on: https://covid-19-market-insights.blogspot.com

Industry Dynamics: Animal Parasiticides Market Revenue, Growth Rates, and Industry Challenges in 2020-2027

according to a new report published by research dive, the global animal parasiticide market forecast will be $7,082.2 million by 2026, rising from $5,096.0 million in 2018, and at 4.2% cagr.

The significant animal parasiticide market drivers; are increasing the adoption of pet animal’s and awareness about the importance of parasiticide products to prevent zoonotic diseases. Increasing knowledge among the people about livestock and livestock healthcare, rising the concerns to control of zoonotic diseases in the animals and livestock is anticipated to lead the market growth in the future time. Additionally, increasing investments to develop improved parasiticide products for veterinary healthcare and rise in the expenditure on animal healthcare are further enhancing the animal parasiticide market growth in a positive manner. Parasiticide product cost and heavy R&D investments are projected to hamper the global animal parasiticide market. Animal parasiticide market advancements and rise in the government implementations to prevent the animal and livestock health are expected to generate major opportunities for the new entrants into the market in the coming years.

Connect with Analyst to Reveal How COVID-19 Impacting On Market: https://www.researchdive.com/connect-to-analyst/56

Ectoparasiticide type market will witness a significant growth and is estimated to generate a revenue of $1,678.5 million, at a 4.6% CAGR over projected period. The rise in the demand of ectoparasiticides type to prevent or control parasite insects in animals is anticipated to boost the market growth in the coming years. Endectocides type dominated the global animal parasiticide market, it is registered for $2,293.2 million in 2018, and is projected to account for $3,109.1 million by the end of 2026. This is due to endectocides are major veterinary parasiticide that are used for the treatment of arthropods and nematodes insects affecting animals. Additionally, increase the use of endectocides to minimize parasites diversity is expected to drive the animal parasiticide market in the projected period.

The companion animals segment is expected to experience the substantial growth, it is estimated to register of $2,323.0 million, growing at a highest rate of 4.5% in the projected time frame. This is owing to the growing requirements from pet owners and veterinary centers to prevent or treat animals from the zoonotic diseases. Additionally, rise in the animal healthcare expenditure and number of pet owners are expected to enhance the animal parasiticide market over forecast timeframe. The farm animals segment has registered the highest animal parasiticide market share of 68.0% in 2018, and is estimated to generate revenue of $4,759.3 million, growing at 4.0% CAGR over projected period. This growth is attributed to high quantity requirement of parasiticides, due to huge quantity of farm animals present across the globe.

Download Exclusive Free Sample Copy of the Report at: https://www.researchdive.com/download-sample/56

Asia-Pacific market is projected witness a noteworthy growth rate, it is projected to account for $ 1,614.8 million and at a CAGR of 4.7% in the projected time period, owing to upsurge in the adoption of animals, and increase in the product demand from the quality meat consumers across the region. Additionally, rising awareness about the importance of parasiticides to control the diseases will further drive the market growth in the coming years. North America market is accounted for the highest animal parasiticide market size of $1,885.5 million in 2018, it is estimated to register of $2,556.7 million and at a 3.9% CAGR, owing to rising interest of pet animals owning among the people.

Elanco, Boehringer Ingelheim animal Health, Ceva Santé Animale, Vetoquinol, Eli Lilly, Bayer AG Zoetis Inc., Sanofi, Merck Co., and Perrigo Company Plc, are some of the animal parasiticide market players. These manufacturers are accepting the key approaches such as product infections, collaboration and partnerships in order to rise their market size in the global animal parasiticide market. For example, in September 2019, Zoetis Inc. presented positive effectiveness of triple combination of parasiticide at American Heartworm Society Meeting, which is useful for preventing animals from heartworm disease and to control and treat of fleas, intestinal and ticks in dogs.

Contact Us:

Regional Outlook: Intrathecal Drug Delivery System Market by Key Vendors, Challenges and Opportunities 2027

according to a study of research dive, intrathecal drug delivery system market forecast shall surpass $1662 million by 2027, registering a cagr of 7.2% from 2019 to 2027.

Intrathecal drugs delivery (IDD) system plays the important role in the treatments of intractable (uncontrollable) pain. IDD system utilized for selected patients which are associated with major reduction in quality of health and that have not options of other treatment. This treatment requires highly specialized team for ensuring appropriate selection along with the safety criteria.

IDD enables therapist to formulate individualized treatment regimens which can provide improved analgesia with small doses coupled with fewer adverse effects over opioid-based therapies.

The major factors that boost the global intrathecal drug delivery system market growth are rising demand for intrathecal drug delivery system for cancer pain. In addition, surge in cost-effective cancer pain treatment using such systems are expected to boost the market growth during the forecast period. However, complications of ITDD systems hamper the growth of the intrathecal drug delivery system market.

Download Exclusive Free Sample Copy of the Report at: https://www.researchdive.com/download-sample/43

Externalized and Connected with a pump holds the highest market share amongst the product type segment and is expected to register revenue of $1,358.6 million during the forecast period 2020-2027 at a CAGR of 6.8%. Externalized and connected with a pump is used in situations wherein there’s frequent need of change of catheter such as those who are suffering from cancer. They are in trend as they are cost effective compared to fully implanted systems.

These pumps have proved to be very effective for cancer pain and have been use since the last 3-4 decades and they are still in use as fully implanted systems are still in R&D phase and are not use in major developing countries.

Amongst the Application segment, Spasticity Management for intrathecal drug delivery system market size, generating revenue of $635.1 million in 2018, and is expected to grow at CAGR of 7.1% registering revenue of $1,140.2 million by 2027. ITDD devices are mostly used for spasticity management and with advent of programmable system the spasticity can be managed by controlling the flow of drug delivery. They are majorly used in European countries like Belgium, Germany, UK and others. These systems have opportunities in the developing countries wherein the spasticity problems are more pronounced.

North America has the highest Intrathecal drug delivery system market share globally and is expected to register revenue of $695.9 million growing at a healthy rate of 7.4% over the forecast period. Due to ease usage which signifies better control and long lasting nature of the Intrathecal devices North America market has highest market share for implanted Intrathecal drug device Therefore, it is one of the significant factor for growth of Intrathecal drug devices market.

Connect with Our Analyst to Contextualize Our Insights for Your Business: https://www.researchdive.com/connect-to-analyst/43

U.S, hold the majority of the share of the North America market and it is one of the leading countries globally. Companies are spending heavily on research & Development activities, in order to provide innovative and effective pain management solution thereby driving the growth of Intrathecal Drug delivery systems in the country.

Prominent players in Intrathecal Drug Delivery Systems are Medtronic plc is one of the potential manufacturers of programmable intrathecal drug Delivery Systems has successfully launched the Medtronic SynchroMed II (drug infusion pump), which is utilized to deliver drug into a patient’s body. The pump is used together with a catheter to deliver a specific drug to the patient’s spinal fluid. Other major players include Flownix Medical Inc, Teleflex Incorporated, DePay Synthes, Tricumed Medizintechnik GmbH, Smiths Group Plc, Summit Medical Group, B Braun Melsungen AG, Becton, Dickinson & Company and Fresenius Medical Care AG & Co. KGaA.

Contact Us:

Qualitative Analysis: Medical Marijuana Market - Future Growth, Verticals, Segmentation & Forecast to 2027

as per study of research dive, medical marijuana (cannabis) market forecast revenue of $36,205.4 million in the year 2026 growing at cagr of 28.7%.

Marijuana is more safe and has less severe side effects over other treatment options such as opioid-based treatments. It is more efficient in reducing nausea and also improving appetite among chemotherapy patients. Increasing cancer burden along with rising demand for chronic pain management & treatment is projected to drive the medical marijuana market growth. For instance, as per publication of the World Health Organization (WHO), in 2018, Cancer disease is the second leading cause of death cases, in which Lung, breast, prostate, liver, stomach and colorectal cancer are the common types of cancerous diseases. Moreover, R&D activities, Clinical trials along with commercialization of cannabis are anticipated to boost the global medical marijuana industry. However, stringent government regulation, lack of awareness in the emerging countries and absence of proper information shall restrain the medical marijuana market growth. China has the significant opportunities for the medical marijuana market; this is majorly due to China is primarily involved in the research and also it has heavy production of marijuana. Moreover, key players such as Hanma Investment Group received permission to extract CBD (Cannabidiol) in China. Currently this company exports 90% of its production, to the countries such as, Germany, the U.K., and the US.

Connect with Analyst to Reveal How COVID-19 Impacting On Market: https://www.researchdive.com/connect-to-analyst/59

Pain management segment shall generate revenue of $15,133.9 million in 2026, increasing at a CAGR 28.2%. Pain management segment is broadly classified into neuropathic pain, cancer pain, and others. Rising prevalence of cancerous diseases attributed to primarily increase the necessity of pain management across the globe is anticipated to foster the global market.

Inhalation segment shall generate revenue of $25,162.8 million by the end of 2026, at a CAGR of 28.1% till 2026.This segment has enormous opportunities due to properties such as reduction in noxious emissions and quick effects. Topical segment shall generate revenue of $7,965.2 million by the end of 2026, at a CAGR of 30.2% till 2026.

Online segment will see enormous growth owing to, easy accessibility and significant changes in the legality of marijuana attributed to increasing need of E-commerce payment system in cannabis market will generate revenue of $9,558.2 million by the end of 2026, rising at a CAGR 32.3%. Dispensaries segment is expected to generate revenue of $26,647.2 million by the end of 2026, growing at a CAGR of 27.6%.

North America medical marijuana market size will cross $11,404.7 million in 2026, increasing at a CAGR 26.6%. North America marijuana market is anticipated to increase at fast rate owing to legalization of medical marijuana in Canada, in addition, extensive growth in cannabis based products for medicinal use and legalization of cannabis by the House Judiciary Committee in the US is expected boost the market in this regions.

Download Exclusive Free Sample Copy of the Report at: https://www.researchdive.com/download-sample/59

Medical Marijuana market share for Asia-Pacific region is projected to grow at a CAGR of 30.8% by generating a revenue of $8,037.6 by 2026. Asia Pacific region is projected to witness significant growth owing to the piecemeal legalization of medicinal cannabis in the nations such as Australia and Israel. Additionally, Thailand is the nation that has fully legalized medicinal marijuana with multiple clinical applications.

Some of the significant medical marijuana market players are: mCig, Emerald Health Therapeutics, ABcann Medicinals, Inc., Insys Therapeutics, Inc., Aphria, Inc., Cannabis Sativa Inc., Canopy Growth Corporation, GW Pharmaceuticals, Green Relief Inc., and Aurora Cannabis, Inc. These players are initiating various steps in order strengthen their presence such as merger & acquisitions, new product development. For example, to meet the demand of rising number of patients, Green Relief Inc., a licensed manufacturer of marijuana based therapeutic medicines, has officially acquired a new facility department in Canada.

Contact Us:

Corona Impact: Is Intensive Care Beds Market will Propel with its Advanced Approaches in 2020

The emergency of the COVID-19 pandemic is expected to affect the global intensive care beds market in a positive way. During this outbreak, the development of healthcare services across the globe will support the treatment of seriously unwell patients infected by the novel coronavirus. These patients require to be admitted in specialized critical care units to minimize the infection from the virus. Also, about 5% of coronavirus cases are predicted to need ICU admission for quick recovery from the virus. These factors are anticipated to increase the demand for intensive care beds and is projected to boost the market growth in the outbreak time.

In addition, major players in the market are adopting various strategies such as new technology launches and geographical expansions to upsurge their market share in the global industry. For example, in July 2020, Stryker, a leading company in medical technology, launched new ambulatory surgery center (ACS) to provide cost effective healthcare services in the pandemic period as well as in the post emergency environment. This aspect will impel the market growth in the forecast time. This report is designed to help our customers in understanding the condition of global intensive care beds market in this unprecedented period.

Connect with Our Analyst to Contextualize Our Insights for Your Business: https://www.researchdive.com/connect-to-analyst/361

• Our report includes:

– Technological Impact
– Social Impact
– Investment Opportunity Analysis
– Pre- & Post-COVID Market Scenario
– Infrastructure Analysis
– Supply Side & Demand Side Impact

As per a new report published by Research Dive, the global intensive care beds market is estimated to register a revenue of $2,202.9 million till 2027 and is expected to grow at a notable rate of 4.2% CAGR during the projected time from 2020 to 2027. The global market classification has been done based on product, application, end use and region. This report delivers complete information about drivers, opportunities, restraints, segmentation and significant manufacturers in the global market.

• Factors affecting the market growth

As per our analysts, growing healthcare investments and increasing hospital admissions around the world are significantly driving market growth in the projected time. Nevertheless, high costs of intensive care beds is expected to be the major restraint for the intensive care beds market growth.

• Manual beds product is expected to grow at a notable rate

By product, the global market has been divide into electrical beds, manual beds and others beds. Among these, manual beds segment is expected to witness a noteworthy growth during the review period and is expected to account for $764.4 million by 2027. Rising demand for manual beds due to its low maintenance and less expensive compared with other beds, which will drive the market growth in the forecast time.

• General ICU’s application and ambulatory surgical centers segments are projected to have significant growth

By application, the global market is classified into general ICU’s, pediatric & neonatal ICU’s and specialized ICU’s. In these, the general ICU’s application segment dominated the global market size in 2019 and is expected to reach $874.6 million till 2027. Extensive utilization of intensive care beds for general ICU’s application due to support to treat high number patients. This factor will fuel the market growth during the estimated period.

Download Exclusive Free Sample Copy of the Report at: https://www.researchdive.com/download-sample/361

By end use, the global market is classified into hospitals, ambulatory surgical centers and others. In these, ambulatory surgical centers end use segment will witness to grow at a healthy CAGR of 4.0% and is expected to register a revenue of $605.8 million in 2027. Growing number of ambulatory surgical centers due to minimize the healthcare expenditure and these centers bed capacity can be increase based on requirement, these aspects will accelerate the growth of the market in the coming years.

• Intensive care beds market, regional overview

The global intensive care beds market has been examined across several regions such as North America, Europe, Asia-Pacific and LAMEA. Among these, North America produced majority of the intensive care beds market share in 2019, which was approximately 35.0% and is projected to endure its dominance over the global industry throughout the prediction period. Along with, Asia-Pacific occupied subsequent position in the global market share in the previous years and is anticipated to reach $583.8 million till 2027. In Asia-Pacific, increasing elderly population along with rising hospital admissions in the critical care units are projected to drive the growth of the market in the forecast years.

• Top 10 Significant Players in the Global Intensive Care Beds Market Includes:

1. Invacare Corporation
2. Hillrom
3. LINET
4. Merivaara Corp.
5. Span America
6. Stryker
7. Medline Industries, Inc.
8. Getinge AB
9. Malvestio Spa
10. Stiegelmeyer GmbH & Co. KG

Contact Us:

COVID-19 Impact Review: What Challenges Left Atrial Appendage Closure Devices Market May See In Next 5 Years?

The COVID-19 outbreak has significantly affected the global left atrial appendage closure devices market. As per American Heart Association, people having high blood pressure, heart valve disease and congenital heart diseases are expected to develop severe coronavirus symptoms. Also, this virus can generate heart strokes through weakening of muscles of the heart. These fators will boost the demand for left atrial appendage closure divices and surge the market growth during the pandemic.

Furthermore, the leading manufactures in the global market are adopting various strategies such as product innovations and partnerships to increase their market share in the overall industry. For example, in July 2020, Boston Scientific Corporation announced that the “Watchman FLX left atrial appendage closure device” has been approved by U.S. Food and Drug Administration, which is used to minimize the threat of heart stroke in patients. The stroke reduction technologies are intended to improve technical safety and performance as well as treat large number of patients with non-valvular atrial fibrillation. During the chaotic COVID-19 situation, we are helping our clients in understanding the impact of COVID-19 on global left atrial appendage closure devices.

• Our report includes:

– Technological Impact
– Social Impact
– Investment Opportunity Analysis
– Pre- & Post-COVID Market Scenario
– Infrastructure Analysis
– Supply Side & Demand Side Impact

As per the recent study done by Research Dive, the global left atrial appendage closure devices market will reach up to $2,637.1 million in 2027, rising at a notable CAGR of 24.0% in the forecast time. The market segmentation has been done based on product, procedure, end-use, and region. The report provides detailed information on opportunities, driving factors, segments analysis, restraints, and key players in the market.

• Factors Affecting the Market Growth

As per our analyst estimates, the rising prevalence of atrial fibrillation diseases owing to the change in lifestyles are some of the major factors propelling the global market growth. However, lower product penetration in middle and low-income countries are predicted to restrain the growth of the left atrial appendage closure devices market.

• Endocardial LAA closure devices product and percutaneous procedure segment held the global market size

Based on a product, the global market is categorized into endocardial LAA closure devices and epicardial LAA closure devices. In both of these, endocardial LAA closure devices segment held the global market size, it was valued over $359.3 million in 2019 and is anticipated to continutes its trend in the global market throughout the forecast years. This dominance is majorly attributed to extensive use of endocardial procedures in atrial fibrillation in the previous years.

Based on procedure, the global market is majorly is categorized into surgical and percutaneous. Among these, percutaneous procedure accounted for majority of the left atrial appendage closure devices market share in the previous time, which was 85.0% and is projected to generate a revenue of $2,188.8 million till 2027. Percutaneous is widely utilized procedure due to several benefits such as minimize angina and better results in coronary artery diseases. This aspect will propel the market growth during the forecast time.

• Hospital segment dominated highest revenue share

Based on end-use, the global left atrial appendage closure devices market is classified into hospitals, ambulatory surgey centers and others. Among these, hospitals end use accounted for largest left atrial appendage closure devices market share in the previous years and is expected to reach up to $1,569.1 million by the end of 2027. Increasing number of hospital admissions along with rising investments to advance healthcare facilities is expected to fuel the market growth during the estimated period. Along with, ambulatory surgery centers segment will witness to rise at a notable rate of 24.4% CAGR during the projected time and projected to account for $812.2 millions by 2027.

• Left atrial appendage closure devices market, geographical Analysis

The North America dominated the global left atrial appendage closure devices market size in 2019, it valued at $172.6 million and is projected to surge at a growth CAGR of 23.4% during the prediction period. High prevelance rate of atrial fibrillation owing to change in lifestyle and early adoption of LAA closure devices due to improved healthcare infrastructure are projected to drive the market growth in the North America. Along with, Europe accounted for subsequent position in the overall marketplace in 2019 and is expected to be the most lucrative region throughout the forecast time. Increasing investments on technological developments expecially in Germany, UK and many other European countries, this factor will accelerate the growth of the market in the coming time.

• Top 10 Leading Players in the Left Aatrial Appendage Closure Devices Market Includes:

1. SentreHEART, Inc.
2. Boston Scientific Corporation
3. AtriCure, Inc.
4. Abbott.
5. Occlutech
6. Lifetech Scientific
7. Cardia, Inc.
8. Aegis Medical Group.
9. Biosense Webster, Inc.
10. Johnson & Johnson Services, Inc.

Contact Us:

Is Home Infusion Therapy Market Trapped Between Growth Expectations And Uncertainty?

Home infusion therapy market will witness to have a positive impact with the pandemic in 2020. Rising geriatric population across the globe is predicted to be the major driving factor for the market in the estimated period. Moreover, increasing prevalence of chronic diseases is predicted to drive the market in the estimated period. Presence of complicated reimbursement policies is predicted to be the biggest restraint for the market in the estimated time frame. During this unpredicted situation, we are helping our clients in understanding the impact of COVID19 on the global market.

• Our report includes:

– Technological Impact
– Social Impact
– Investment Opportunity Analysis
– Pre- & Post-COVID Market Scenario
– Infrastructure Analysis
– Supply Side & Demand Side Impact

According to a study conducted by Research Dive, the global home infusion therapy market is expected to register a revenue of $49.5 billion till 2027, growing at a rate of 11.7% CAGR during, 2020-2027. The global market is classified on the basis of product and application. The report provides detailed information about drivers, opportunities, restraints, segmental analysis and competitive players of the market

Download Exclusive Free Sample Copy of the Report at: https://www.researchdive.com/download-sample/360

• Factors Affecting the Market Growth

As per our analyst, rise in the geriatric population among the population across the region is predicted to be the major driving factor for the market in the forecast period. Moreover, Presence of complicated reimbursement policies is predicted to be the biggest restraint for the market in the estimated time frame.

• Infusion Pumps Segment is predicted have the Highest Growth Rate

On the basis of product, the global home infusion therapy market is further classified into needleless connectors, intravenous sets, infusion pumps and IV cannulas. Infusion Pumps is predicted to grow with a CAGR of 11.8% by generating a revenue of $25.4 billion by 2027. Increasing adoption of infusion pump for treating geriatric population and rising demand for syringe is predicted to boost the segment market in the estimated period.

• Anti-Infective is predicted to Have Highest Market Share

On the basis of application, the global home infusion therapy market is further classified into anti-infective, hydration therapy, chemotherapy, enteral nutrition, parenteral nutrition, specialty pharmaceuticals and others. Anti-Infective segment is predicted to grow with a CAGR of 12.5% by generating a revenue of $12.1 billion by 2027.Increasing adoption of anti-fungal and antibiotic drug reduces the exposer to patient with other hospital acquired infection is predicted to drive the market in the forecast period.

Connect with Our Analyst to Contextualize Our Insights for Your Business: https://www.researchdive.com/connect-to-analyst/360

• Regional Breakdown of the Market

On the basis of region, the global home infusion therapy market is further classified into North America, Europe, Asia-Pacific and LAMEA. North America region is predicted to grow with a CAGR of 11.5% by generating a revenue of $17.1 billion by 2027. Increasing adoption of new technology and rise development of alternate healthcare setting is predicted to boost the region market in the estimated timeframe.

• Top 11 Prominent Players in the Home Infusion Therapy Market are –

1. Cosmed
2. Terumo Corporation
3. Smiths Medical.
4. JMS Co., Ltd.
5. ICU Medical Inc.
6. Fresenius Kabi
7. Eli Lilly and Company
8. Becton
9. Dickinson and Company (BD)
10. Baxter International, Inc.
11. B Braun Melsungen AG

Contact Us:

How Protective Face Masks Market Will Grow In Coming Future Despite COVID-19 Chaos?

The pandemic is predicted to have a positive impact on the global protective face masks market. Increasing surgeries and rise in the awareness regarding the benefits of masks is predicted to be the major driving factor for the market in the estimated timeframe. Majority of the company are focusing more in their research and development for the production of their mask as the demand of the masks is very high which is predicted to drive the market in the estimated period. For instance, In August 2020, Notion VTec garners investor interest after registration with US FDA as face mask manufacturer. The interest comes as investors continue to show interest in healthcare-linked stocks amidst the Covid-19 pandemic. During this unpredicted situation, we are helping our clients in understanding the impact of COVID19 on the global market.

• Our report includes:

– Technological Impact
– Social Impact
– Investment Opportunity Analysis
– Pre- & Post-COVID Market Scenario
– Infrastructure Analysis
– Supply Side & Demand Side Impact

According to a study conducted by Research Dive, the global protective face mask market is expected to register a revenue of $2,467.5 million till 2027, growing at a rate of 10.8% CAGR during, 2020-2027. The global market is classified depending on product, distribution channel and end use. The report provides detailed information about drivers, opportunities, restraints, segmental analysis and competitive players of the market.

Connect with Analyst to Reveal How COVID-19 Impacting On Market: https://www.researchdive.com/connect-to-analyst/359

• Factors Affecting the Market Growth

As per our analyst, Rise in the demand of the protective face mask across the globe due to the pandemic is predicted to be the biggest driving factor for the global market in the estimated period. Moreover, low profit margin for the manufacturer is predicted to hinder the market in the estimated timeframe.

• N95 Respirators is Projected to Have Highest Market Share

Depending on product, the protective face mask market is divided into procedure mask, N95 respirators, face shields and surgical mask. N95 respirators segment is predicted to rise at a CAGR of 11.6% by generating a revenue of $392.3 million by 2027. N05 masks are safer and are helpful in protecting various types of bacteria and pollution at a most cost effective manner due to which it is predicted to drive the market in the forecast period.

• Pharmacies segment is Projected to Grow Enormously

Depending on distribution channel, the protective face mask market is divided into distributors, online and pharmacies. Pharmacies segment is predicted to grow at a CAGR of 10.6% by generating a revenue of $1,048.7 million by 2027. At present, everyone needs to wear a mask to prevent being affected by the coronavirus, which is predicted to boost the segment in the projected period.

Download Exclusive Free Sample Copy of the Report at: https://www.researchdive.com/download-sample/359

• Hospitals and Clinics is Projected to Hold Maximum Market Share

Depending on distribution channel, the protective face mask market is divided into hospitals and clinics, individuals, long term care centers, ambulatory surgical centers, research institutes and other. Individual segment is predicted to grow at a CAGR of 11.5% by generating a revenue of $467.5 million by 2027. Increasing awareness among the patient regarding the usages of mask is predicted to boost the segment market in the estimated timeframe.

• Regional Breakdown of the Market

Depending on region, the protective face mask market is divided into North America, Europe, Asia-Pacific and LAMEA. North America region market is predicted to grow at a CAGR of 10.4% by generating a revenue of $913.0 million by 2027. Rise in the corona cases and the rise in the customer base across the region is predicted to boost the region market in the forecast period. Moreover, Presence of major companies across the region is predicted to be the major driving factor for the market in the forecast period.

• Top 10 Prominent Players in the Protective Face Mask Market are-

1. Reckitt Benckiser Group plcR
2. Polison Corporation
3. Intech Safety Private Limited
4. Mine Safety Appliances (MSA) Company
5. Delta Plus Group
6. Ansell Limited
7. Alpha Solway Ltd
8. JSP Ltd.
9. Moldex-Metric, Inc.
10. 3M

Contact Us:

COVID-19 Outbreak: How Medical Pendant Market Will Shape Having Biggies with Strong Fundamentals?

The COVID-19 pandemic is expected to impact the global medical pendant market in positive way and is projected to experience a significant growth in the forecast years. In recent times, World Health Organization (WHO) has given new guidance on healthcare financing policies which is primarily focusing on strengthening healthcare systems and health security during the COVID-19 emergency. This factor is eventually predicted to drive the demand for improvement of hospital facilities, which is expected to propel the market growth. Nevertheless, the COVID-19 emergency has a considerable effect on supply chains between manufacturers and contractors owing to shutdown of several industries activities across the globe. Growing government supports to maintain constant supply of medical equipment’s to meet consumer demand. These aspects are expressively affecting the medical pendant market growth during the emergency period.

In addition, some of the governments are executing various initiatives to help the organizations in the pandemic time. For example, the Spain government has announced new economic measures for the supply of medical equipment’s and accessories from manufacturers to hospitals, public bodies and NGO’s. In this announcement, VAT tax is reduced to zero percentage and the VAT on magazines, newspapers and books has also been minimized. During this unpredicted condition, we are helping the market players in understanding the impact of COVID-19 on the global medical pendant market.

• Our report includes:

– Technological Impact
– Social Impact
– Investment Opportunity Analysis
– Pre- & Post-COVID Market Scenario
– Infrastructure Analysis
– Supply Side & Demand Side Impact

According to new study published by Research Dive, the global medical pendant market will reach up to $775.1 million till 2027 and is predicted to grow at a noteworthy CAGR of 8.1% throughout the projected period 2020-2027. The global market segmentation has been done on the basis of material product, installation, application, end user and region. This report offers complete insights of drivers, opportunities, restraints, segmentation and prominent manufacturers of the market.

• Factors affecting market growth

As per our analysts predicts, rapidly growing demand for medical pendants along with growing investments to improve hospital amenities are significantly driving the market growth in the forecast period. However, huge initial investments are required for the installation of the medical pendants is expected to restrict the growth of the market.

Connect with Our Analyst to Contextualize Our Insights for Your Business: https://www.researchdive.com/connect-to-analyst/358

• Fixed pendant and ceiling mounted pendant segment contributed a major market share in 2019

By product, the global market is segmented into fixed pendant and movable pendant. In both of these, fixed pendant generated for highest medical pendant market size, it was valued at $213.6 million in 2019 and is expected to generate a revenue of $372.1 million by the end of 2027. High usage of fixed pendants due to its benefits such as light weight, economic and easy use & installation, which is predicted to accelerate the market growth in the forecast time. Besides fixed pendant, movable pendant will experience a remarkable growth and is expected to grow at a highest rate of 9.1% CAGR during the prediction period. Increasing use of movable pendant systems in the ICU and hospitals due to utilize in multiple operations with high performance. This factor is anticipated to fuel the market growth in the upcoming time.

By installation, the global market is segmented into ceiling mounted pendant and wall mounted pendant. Among these, ceiling mounted pendant held the global market share in 2019 and is expected to continue its dominance in the forecast time. Growing usage of ceiling mounted pendant in the hospitals due to it is equipped with medical rails, medical accessories, wound care items and many others. This aspect will boost the medical pendant market growth in the projected time.

• ICU and ambulatory surgical centers segments are anticipated to have lucrative growth

Based on application, the global market has been categorized into general surgery, endoscopy, ICU, anesthesia and others. Among these, general surgery accounted for the significant medical pendant market size in the previous time and will witness to grow at a healthy CAGR of 7.7% in the forecast years. This dominance is accredited to wide utilization of medical pendants in the general surgery operations to conduct various operations. The market for ICU applications is expected to rise at a noteworthy rate of 8.7% CAGR during the estimated period, due to increasing hospital investments on ICU units is directly rising demand for medical pendants and is predicted to drive the market growth in the coming years.

Based on end user, the global market has been categorized into hospitals, ambulatory surgical centers and others. Among these, hospitals segment accounted for major revenue share in the previous years and is anticipated to have a steady growth in the global market during the forecast time. Hospitals are well equipped with advanced equipment’s and high quality accessories to perform surgeries, which will boost the market growth in the projected time. Ambulatory surgical centers will witness to rise at a notable rate of 8.9% CAGR and is expected to experience a remarkable growth during the estimated time. This expected growth majorly attributed to rising adoption of medical pendants in the ambulatory surgical centers to perform emergency operations.

Download Exclusive Free Sample Copy of the Report at: https://www.researchdive.com/download-sample/358

• Medical pendant market, Regional outlook

North America dominated the global medical pendant market share in 2019, which was 40.0% and is predicted to remain its growth over the global market throughout the analysis timeframe. Presence of significant manufacturers along with well-developed healthcare facilities is encouraged the utilization of medical pendants, which will drive the market growth in the forecast time. Along with North America, Asia-Pacific will witness to grow at a significant rate of 8.7% CAGR during the forecast time and is estimated to create huge growth prospects in the upcoming years. Growing healthcare investments along with government favorable implementations to improve medical devices adoption are the major factors for the growth of the market in Asia-Pacific region.

• Top 11 Prominent Players in the Medical Pendant Market are-

1. Hutz MedicalHu
2. Bradon Medical
3. Surgiris
4. Mediland
5. Amico
6. Ondal Medical Systems GmbH
7. Starkstrom
8. SKYTRON, LLC
9. BeaconMedaes
10. Tediselmedical
11. Trivitron Healthcare

Contact Us: